- Home
- LFCR vs NCZ Comparison
LFCR vs NCZ Comparison
Compare LFCR & NCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- NCZ
- Stock Information
- Founded
- LFCR 1986
- NCZ 2003
- Country
- LFCR United States
- NCZ United States
- Employees
- LFCR N/A
- NCZ N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- NCZ Finance Companies
- Sector
- LFCR Health Care
- NCZ Finance
- Exchange
- LFCR Nasdaq
- NCZ Nasdaq
- Market Cap
- LFCR 224.6M
- NCZ 248.9M
- IPO Year
- LFCR N/A
- NCZ N/A
- Fundamental
- Price
- LFCR $6.36
- NCZ $11.51
- Analyst Decision
- LFCR Buy
- NCZ
- Analyst Count
- LFCR 3
- NCZ 0
- Target Price
- LFCR $8.00
- NCZ N/A
- AVG Volume (30 Days)
- LFCR 127.8K
- NCZ 533.0K
- Earning Date
- LFCR 01-02-2025
- NCZ 01-01-0001
- Dividend Yield
- LFCR N/A
- NCZ 12.16%
- EPS Growth
- LFCR N/A
- NCZ N/A
- EPS
- LFCR N/A
- NCZ N/A
- Revenue
- LFCR $130,858,000.00
- NCZ N/A
- Revenue This Year
- LFCR $2.24
- NCZ N/A
- Revenue Next Year
- LFCR $7.88
- NCZ N/A
- P/E Ratio
- LFCR N/A
- NCZ N/A
- Revenue Growth
- LFCR 16.47
- NCZ N/A
- 52 Week Low
- LFCR $3.68
- NCZ $2.50
- 52 Week High
- LFCR $7.99
- NCZ $3.15
- Technical
- Relative Strength Index (RSI)
- LFCR 58.66
- NCZ 23.49
- Support Level
- LFCR $6.00
- NCZ $11.62
- Resistance Level
- LFCR $5.96
- NCZ $11.95
- Average True Range (ATR)
- LFCR 0.29
- NCZ 0.22
- MACD
- LFCR 0.09
- NCZ -0.08
- Stochastic Oscillator
- LFCR 81.51
- NCZ 6.56
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About NCZ Virtus Convertible & Income Fund II of Beneficial Interest
Virtus Convertible & Income Fund II is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. Its portfolio of investments includes different sector investments such as in healthcare services, media, oil, gas and consumable fuels and others.